CClinicalTrials.gg
Status unknownNCT03449602MICROUpdated Mar 29, 2023

Minirigid Versus Conventional Rigid Thoracoscopy in Undiagnosed Pleural Effusions

An interventional study of Mini-thoracoscopy and Conventional rigid thoraoscopy in Pleural Effusion, sponsored by Post Graduate Institute of Medical Education and Research, Chandigarh. Status unknown at 1 site in India. Open to participants aged 15 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-03-29.

Sponsored by Post Graduate Institute of Medical Education and Research, Chandigarh · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
15 Years to 80 Years
Sex
All
01

Study summary

Consecutive patients who are planned to undergo a medical thoracoscopy for obtaining pleural biopsies will be enrolled in the study.

One hundred subjects will be randomized in 1:1 ratio to undergo thoracoscopy to the following groups:

Group A (mini-thoracoscopy) Group B (Conventional rigid thoracoscopy) Primary outcome: (a) diagnostic sensitivity of mini-thoracoscopy and conventional rigid thoracoscopy in the diagnosis of exudative pleural effusions

Read the detailed description

A significant proportion of patients with pleural effusions remain undiagnosed after performance of diagnostic procedures including cytological and microbiologic analysis of the pleural fluid and closed pleural biopsies. In this study, the investigators plan to compare the yield and safety of mini-thoracoscopy and conventional rigid thoracoscopy with the larger diameter scope.

This is a prospective study that will be conducted at the Thoracic Endoscopy Suite of the Department of Pulmonary Medicine, PGIMER, Chandigarh.

Consecutive patients who are planned to undergo a medical thoracoscopy for obtaining pleural biopsies will be enrolled in the study

One hundred subjects will be randomized in 1:1 ratio to undergo thoracoscopy. The randomization sequence will be generated using a computer (in blocks of 10), and the allocation will be placed in opaque sealed envelopes. The patients will be randomized to the following groups:

Group A (mini-thoracoscopy): The mini-thoracoscope manufactured by Richard Wolf GmbH, Knettligen, Germany will be used. It has an outer diameter of 5.5 mm and a working channel diameter of 3.5 mm.

Group B (Conventional rigid thoracoscopy): The rigid thoracoscope manufactured by Richard Wolf GmbH, Knettligen, Germany will be used that has an outer diameter of 10 mm and channel internal diameter of 5 mm.

Primary outcome: (a) diagnostic sensitivity of mini-thoracoscopy and conventional rigid thoracoscopy in the diagnosis of exudative pleural effusions.

02

Conditions studied

  • Pleural Effusion

Browse trials for

Keywords

  • thoracoscopy
  • pleuroscopy
  • metastatic cancer
  • lung cancer
  • malignant pleural effusion
  • tuberculosis
03

Who can participate

Ages eligible
15 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Medical thoracoscopy being performed for obtaining a pleural biopsy

Exclusion criteria

Exclusion Criteria:

  • PaO2/FIO2\< 300; Hemodynamic instability Myocardial infarction or unstable angina in the last 6 wk Lack of pleural space due to adhesions Uncorrected coagulopathy Failure to provide informed consent
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Mini-thoraoscopy

    The mini-thoracoscope manufactured by Richard Wolf GmbH, Knettligen, Germany will be used for performing thoracoscopic pleural biopsies. It has an outer diameter of 5.5 mm and a working channel diameter of 3.5 mm.

    Device: Mini-thoracoscopy

  • Active comparator
    Conventional rigid thoracoscopy

    The rigid thoracoscope manufactured by Richard Wolf GmbH, Knettligen, Germany will be used for performing thoracoscopic pleural biopsies. It has an outer diameter of 10 mm and channel internal diameter of 5 mm.

    Device: Conventional rigid thoraoscopy

Interventions

  • DeviceMini-thoracoscopy

    Thoracoscopic pleural biopsy with the mini-thoracoscope

  • DeviceConventional rigid thoraoscopy

    Thoracoscopic pleural biopsy with the conventional rigid thoraoscope

05

What researchers measure

Primary outcomes

  1. Diagnostic sensitivity (intention-to-treat)

    Difference between the diagnostic sensitivity of mini-thoracoscopy and conventional rigid thoracoscopy in the diagnosis of exudative pleural effusions by calculating the number of true positives diagnosed by thoracoscopic biopsy in the two groups out of the total diseased

    Time frame: 6 months

  2. Diagnostic sensitivity (per protocol)

    Diagnostic sensitivity of mini-thoracoscopy and conventional rigid thoracoscopy in the diagnosis of exudative pleural effusions by calculating the number of true positives diagnosed by thoracocopic biopsy. In this analysis, the subjects crossed over to the rigid group (due to failure of minirigid to yield biopsy tissue) will be considered in the rigid group

    Time frame: 6 months

Secondary outcomes

  1. Sedative and analgesic dose

    Comparing doses of sedative and analgesic agents required in the two groups

    Time frame: 1 day

  2. Pain scores by visual analog scale

    Difference between intraoperative pain score associated with the use of the two devices (assessed after the procedure using the visual analog scale from 0-no pain to 100-maximum possible pain) in the two groups

    Time frame: 1 day

  3. Diagnostic specificity

    Difference between the diagnostic specificity of mini-thoracoscopy and conventional rigid thoracoscopy in the diagnosis of exudative pleural effusions by calculating the number of true negatives diagnosed by thoracoscopic biopsy in the two groups out of those not diseased

    Time frame: 6 months

  4. Adverse effects

    Differences between number of participants with treatment-related adverse events as assessed by CTCAE v4.0 in the two groups

    Time frame: 1 month

  5. Scope maneuverability

    Differences between maneuverability of the two thoracoscopes on a visual analog scale (0-100 mm) assessed by the operator

    Time frame: 1 day

  6. Ease of obtaining biopsy

    Differences between ease of obtaining pleural biopsy with the two thoracoscopes on a visual analog scale (0-100 mm) assessed by the operator

    Time frame: 1 day

  7. Incision size

    Difference in the size of the incision required with the use of the two devices

    Time frame: 1 day

  8. Procedure duration

    Difference in the duration of procedure in the two groups

    Time frame: 1 day

  9. Pain scores by Wong Baker FACES pain rating scale

    Difference between intraoperative pain score associated with the use of the two devices (assessed after the procedure using the Wong Baker FACES pain rating scale) in the two groups

    Time frame: 1 day

06

Study locations

1 of 1 sites recruiting
  • Postgraduate Institute of Medical Education and Research
    Chandigarh, 160012, India
    Recruiting
07

Registry details

Key details

Study ID
NCT03449602
Lead sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Responsible party
Sahajal Dhooria (Assistant Professor, Post Graduate Institute of Medical Education and Research, Chandigarh) — Principal investigator
First posted
Feb 28, 2018
Start date
Mar 1, 2018
Primary completion
Sep 30, 2023 (estimated)
Completion
Sep 30, 2023 (estimated)
Last update
Mar 29, 2023

Study contacts

Sahajal Dhooria, MD, DM
Contact
sahajal@gmail.com
+919530661388
Ritesh Agarwal, MD, DM
Contact
agarwal.ritesh@outlook.in
+919478402976

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion